Advanced search
Publication Cover
Leukemia & Lymphoma Volume 59, 2018 - Issue 3
Submit an article Journal homepage
242
Views
4
CrossRef citations to date
0
Altmetric
Original Articles: Research

Alternative splicing of hTERT: a further mechanism for the control of active hTERT in acute myeloid leukemia

Celeste CalvelloDivision of Hematology, Fondazione IRCCS Policlinico San Matteo University of Pavia, Pavia, Italy; Correspondence[email protected]
,
Barbara RoccaDivision of Hematology, Fondazione IRCCS Policlinico San Matteo University of Pavia, Pavia, Italy;
,
Catherine KlersyService of Biometry and Clinical Epidemiology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy;
,
Rita ZappatoreDivision of Hematology, Fondazione IRCCS Policlinico San Matteo University of Pavia, Pavia, Italy;
,
Ilaria GiardiniDivision of Hematology, Fondazione IRCCS Policlinico San Matteo University of Pavia, Pavia, Italy;
,
Irene DambruosoDivision of Hematology, Fondazione IRCCS Policlinico San Matteo University of Pavia, Pavia, Italy;
,
Francesca PasiDivision of Radiotherapy, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy; ;Department of Biology and Biotechnology, Laboratory of Neuro Radio Experimental Biology, University of Pavia, Pavia, Italy
,
Marilena CaresanaDivision of Hematology, Fondazione IRCCS Policlinico San Matteo University of Pavia, Pavia, Italy;
,
Patrizia ZappasodiDivision of Hematology, Fondazione IRCCS Policlinico San Matteo University of Pavia, Pavia, Italy;
,
Rosanna NanoDepartment of Biology and Biotechnology, Laboratory of Neuro Radio Experimental Biology, University of Pavia, Pavia, Italy
,
Marina BoniDivision of Hematology, Fondazione IRCCS Policlinico San Matteo University of Pavia, Pavia, Italy;
&
Paolo BernasconiDivision of Hematology, Fondazione IRCCS Policlinico San Matteo University of Pavia, Pavia, Italy;
show all
Pages 702-709 | Received 11 Jan 2017, Accepted 17 Jun 2017, Published online: 06 Jul 2017

References

  • Blackburn EH. Telomeres. Trends Biochem Sci. 1991;16:378–381.
  • Van Steensel B, Smogorzewska A, de Lange T. TRF2 protects human telomeres from end-to-end fusions. Cell. 1998;92:401–413.
  • De Lange T. Shelterin: the protein complex that shapes and safeguards human telomeres. Genes Dev. 2005;19:2100–2110.
  • Deville L, Hillion J, Ségal-Bendirdjian E. Telomerase regulation in hematological cancers: a matter of stemness? Biochim Biophys Acta. 2009;1792:229–239.
  • Kilian A, Bowtell DD, Abud HE, et al. Isolation of a candidate human telomerase catalytic subunit gene, which reveals complex splicing patterns in different cell types. Hum Mol Genet. 1997;6:2011–2019.
  • Lincz LF, Mudge LM, Scorgie FE, et al. Quantification of hTERT splice variants in melanoma by SYBR green real-time polymerase chain reaction indicates a negative regulatory role for the beta deletion variant. Neoplasia. 2008;10:1131–1137.
  • Ohyashiki JH, Hisatomi H, Nagao K, et al. Quantitative relationship between functionally active telomerase and major telomerase components (hTERT and hTR) in acute leukaemia cells. Br J Cancer. 2005;92:1942–1947.
  • Engelhardt M, Wäsch R. Telomere length and hTERT expression in patients with acute myeloid leukemia correlate with karyotypic instability. Haematologica. 2005;90:289B.
  • Bechter OE, Eisterer W, Dlaska M. CpG island methylation of the hTERT promoter is associated with lower telomerase activity in B-cell lymphocytic leukemia. Exp Hematol. 2002;30:26–33.
  • Renaud S, Bosman FT, Benhattar J. Implication of the exon region in the regulation of the human telomerase reverse transcriptase gene promoter. Biochem Biophys Res Commun. 2003;300:47–54.
  • Renaud S, Loukinov D, Bosman FT. CTCF binds the proximal exonic region of hTERT and inhibits its transcription. Nucleic Acids Res. 2005;33:6850–6860.
  • Vardiman JW, Thiele J, Arber DA, et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood. 2009;114:937–951.
  • Arber DA, Orazi A, Hasserjian R, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127:2391–2405.
  • Bruedigam C, Lane SW. Telomerase in hematologic malignancies. Curr Opin Hematol. 2016;23:346–353.
  • Baljevic M, Dumitriu B, Lee JW, et al. Telomere length recovery: a strong predictor of overall survival in acute promyelocytic leukemia. Acta Haematol. 2016;136:210–218.
  • Fonseka LN, Tirado CA. Telomerase in acute myeloid leukemia: a molecular update on diagnosis, prognosis, and treatment. J Assoc Genet Technol. 2016;42:105–110.
  • Paiva RM, Calado RT. Telomere dysfunction and hematologic disorders. Prog Mol Biol Transl Sci. 2014;125:133–157.
  • Calado RT, Regal JA, Hills M, et al. Constitutional hypomorphic telomerase mutations in patients with acute myeloid leukemia. Proc Natl Acad Sci USA. 2009;106:1187–1192.
  • Capraro V, Zane L, Poncet D, et al. Telomere deregulations possess cytogenetic, phenotype, and prognostic specificities in acute leukemias. Exp Hematol. 2011;39:195–202.e2.
  • Hartmann U, Brümmendorf TH, Balabanov S, et al. Telomere length and hTERT expression in patients with acute myeloid leukemia correlates with chromosomal abnormalities. Haematologica. 2005;90:307–316.
  • Döhner H, Estey E, Grimwade D, et al. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. Blood. 2017;129:424–447.
  • Mohr B, Bornhäuser M, Thiede C, et al. Comparison of spectral karyotyping and conventional cytogenetics in 39 patients with acute myeloid leukemia and myelodysplastic syndrome. Leukemia. 2000;14:1031–1038.
  • Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(–Delta Delta C(T)) method. Methods. 2001;25:402–408.
  • Xu D, Gruber A, Peterson C, et al. Telomerase activity and the expression of telomerase components in acute myelogenous leukaemia. Br J Haematol. 1998;102:1367–1375.
  • Zhang W, Piatyszek MA, Kobayashi T, et al. Telomerase activity in human acute myelogenous leukemia: inhibition of telomerase activity by differentiation-inducing agents. Clin Cancer Res. 1996;2:799–803.
  • Fonseka LN, Tirado CAJ. Telomerase in acute myeloid leukemia: a molecular update on diagnosis, prognosis, and treatment. Assoc Genet Technol. 2016;42:105–110.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.